Literature DB >> 23602501

Toll-like receptor signalling and their therapeutic targeting in colorectal cancer.

Shirin Moossavi1, Nima Rezaei.   

Abstract

Intestinal homeostasis is dependent on the proper host/microbiota interaction via pattern recognition receptors. Toll-like receptors are a specialised group of membrane receptors which detect pathogen-associated conserved structures. They are present in the intestinal tract and are required for intestinal homeostasis. Dysregulation in the Toll-like receptor signalling can conceivably result in a dysregulated immune response which could contribute to major intestinal pathologies including colorectal cancer. Evidence for the role of microbiota and toll-like receptors in colorectal cancer is emerging. In this report the evidence for the contribution of toll-like receptors to the pathogenesis of colorectal cancer; potential mechanisms affecting toll-like receptor signalling; and their therapeutic targeting in colorectal cancer are reviewed.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23602501     DOI: 10.1016/j.intimp.2013.03.017

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  11 in total

Review 1.  Gastrointestinal malignancy and the microbiome.

Authors:  Maria T Abreu; Richard M Peek
Journal:  Gastroenterology       Date:  2014-01-07       Impact factor: 22.682

2.  Effect of SMYD3 on the microRNA expression profile of MCF-7 breast cancer cells.

Authors:  Dongju Chen; Lei Liu; Xuegang Luo; Ai Mu; Lihua Yan; Xiaoying Chen; Lei Wang; Nan Wang; Hongpeng He; Hao Zhou; Tongcun Zhang
Journal:  Oncol Lett       Date:  2017-06-06       Impact factor: 2.967

3.  IFNAR1 is a predictor for overall survival in colorectal cancer and its mRNA expression correlated with IRF7 but not TLR9.

Authors:  Liang-Che Chang; Chung-Wei Fan; Wen-Ko Tseng; Hui-Ping Chein; Tsan-Yu Hsieh; Jim-Ray Chen; Cheng-Cheng Hwang; Chung-Ching Hua
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

Review 4.  Toll-like Receptors and Inflammatory Bowel Disease.

Authors:  Yue Lu; Xinrui Li; Shanshan Liu; Yifan Zhang; Dekai Zhang
Journal:  Front Immunol       Date:  2018-01-30       Impact factor: 7.561

5.  The Inhibitory Role of M2000 (β-D-Mannuronic Acid) on Expression of Toll-like Receptor 2 and 4 in HT29 Cell Line.

Authors:  Laleh Sharifi; Mona Moshiri; Mohammad M S Dallal; Mohammad H Asgardoon; Maryam Nourizadeh; Saied Bokaie; Abbas Mirshafiey
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2019

Review 6.  Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility.

Authors:  Aga Syed Sameer; Saniya Nissar
Journal:  Biomed Res Int       Date:  2021-09-12       Impact factor: 3.411

7.  Role of toll-like receptor 4 in colorectal carcinogenesis: a meta-analysis.

Authors:  Xiao-Xia Li; Gong-Ping Sun; Jin Meng; Xin Li; Yuan-Xin Tang; Zhen Li; Mo-Fei Wang; Gao-Feng Liang; Xiao-Bo Lu
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

Review 8.  Multiple roles of toll-like receptor 4 in colorectal cancer.

Authors:  Dhanusha Yesudhas; Vijayakumar Gosu; Muhammad Ayaz Anwar; Sangdun Choi
Journal:  Front Immunol       Date:  2014-07-15       Impact factor: 7.561

9.  Divergent expression of bacterial wall sensing Toll-like receptors 2 and 4 in colorectal cancer.

Authors:  Karoliina Paarnio; Sara Väyrynen; Kai Klintrup; Pasi Ohtonen; Markus J Mäkinen; Jyrki Mäkelä; Tuomo J Karttunen
Journal:  World J Gastroenterol       Date:  2017-07-14       Impact factor: 5.742

Review 10.  Human Gut Microbiota and Gastrointestinal Cancer.

Authors:  Changting Meng; Chunmei Bai; Thomas D Brown; Leroy E Hood; Qiang Tian
Journal:  Genomics Proteomics Bioinformatics       Date:  2018-02-21       Impact factor: 7.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.